Cargando…

Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial

BACKGROUND: No real-world randomised controlled trials (RCTs) have explored the effectiveness of lifestyle interventions based on multiple behaviour change theories and using combined digital and group-based face-to-face delivery to improve risk factors for type 2 diabetes (T2D). METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakka, Timo A., Aittola, Kirsikka, Järvelä-Reijonen, Elina, Tilles-Tirkkonen, Tanja, Männikkö, Reija, Lintu, Niina, Karhunen, Leila, Kolehmainen, Marjukka, Harjumaa, Marja, Mattila, Elina, Järvenpää, Riia, Ermes, Miikka, Mikkonen, Santtu, Martikainen, Janne, Poutanen, Kaisa, Schwab, Ursula, Absetz, Pilvikki, Lindström, Jaana, Pihlajamäki, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810821/
https://www.ncbi.nlm.nih.gov/pubmed/36620354
http://dx.doi.org/10.1016/j.lanepe.2022.100527
_version_ 1784863389546184704
author Lakka, Timo A.
Aittola, Kirsikka
Järvelä-Reijonen, Elina
Tilles-Tirkkonen, Tanja
Männikkö, Reija
Lintu, Niina
Karhunen, Leila
Kolehmainen, Marjukka
Harjumaa, Marja
Mattila, Elina
Järvenpää, Riia
Ermes, Miikka
Mikkonen, Santtu
Martikainen, Janne
Poutanen, Kaisa
Schwab, Ursula
Absetz, Pilvikki
Lindström, Jaana
Pihlajamäki, Jussi
author_facet Lakka, Timo A.
Aittola, Kirsikka
Järvelä-Reijonen, Elina
Tilles-Tirkkonen, Tanja
Männikkö, Reija
Lintu, Niina
Karhunen, Leila
Kolehmainen, Marjukka
Harjumaa, Marja
Mattila, Elina
Järvenpää, Riia
Ermes, Miikka
Mikkonen, Santtu
Martikainen, Janne
Poutanen, Kaisa
Schwab, Ursula
Absetz, Pilvikki
Lindström, Jaana
Pihlajamäki, Jussi
author_sort Lakka, Timo A.
collection PubMed
description BACKGROUND: No real-world randomised controlled trials (RCTs) have explored the effectiveness of lifestyle interventions based on multiple behaviour change theories and using combined digital and group-based face-to-face delivery to improve risk factors for type 2 diabetes (T2D). METHODS: We conducted a one-year, multi-centre, unblinded, pragmatic RCT in primary healthcare using the habit formation, self-determination, and self-regulation theories among 2907 adults aged 18–74 years at increased T2D risk randomised into a digital lifestyle intervention group (DIGI, n = 967), a combined digital and group-based lifestyle intervention group (DIGI+GROUP, n = 971), and a control group receiving usual care (CONTROL, n = 969). We collected data on primary outcomes (diet quality by Healthy Diet Index [HDI], physical activity, body weight, fasting plasma glucose, 2-hour plasma glucose) and secondary outcomes (sedentary time, waist circumference, fasting plasma insulin) using digital questionnaires, clinical examinations, fasting blood tests, and 2-hour oral glucose tolerance tests. Main statistical analyses were performed using linear mixed-effects models adjusted for age, sex, and province. This RCT was registered with ClinicalTrials.gov, NCT03156478. FINDINGS: The 2907 participants assigned were recruited between March 1(st), 2017, and February 28(th), 2018. Diet quality improved more (3·2 vs. 1·4 HDI points, p<0·001 for difference between groups, p’<0·001 for group*time interaction) and waist circumference tended to decrease more (−1·8 vs. −1·3 cm, p = 0·028, p’ = 0·068) in DIGI+GROUP than in CONTROL. Fasting insulin tended to increase in CONTROL but not in DIGI (1·0 vs. 0·0 mU/L, p = 0·033, p’ = 0·054) or in DIGI+GROUP (1·0 vs. 0·5 mU/L, p = 0·042, p’ = 0·054). Good adherence to DIGI and DIGI+GROUP (≥median of 501 habits/year in DIGI, ≥5 of all 6 sessions in GROUP) was associated with improved diet quality and good adherence to DIGI with increased physical activity and decreased sedentary time. INTERPRETATION: A lifestyle intervention based on multiple behaviour change theories and combined digital and group-based face-to-face delivery improves diet quality and tends to decrease abdominal adiposity and prevent an increase in insulin resistance. Good adherence improves the results of the interventions. FUNDING: Strategic Research Council at Academy of Finland, Academy of Finland, Novo Nordisk Foundation, and Finnish Diabetes Research foundation.
format Online
Article
Text
id pubmed-9810821
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98108212023-01-04 Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial Lakka, Timo A. Aittola, Kirsikka Järvelä-Reijonen, Elina Tilles-Tirkkonen, Tanja Männikkö, Reija Lintu, Niina Karhunen, Leila Kolehmainen, Marjukka Harjumaa, Marja Mattila, Elina Järvenpää, Riia Ermes, Miikka Mikkonen, Santtu Martikainen, Janne Poutanen, Kaisa Schwab, Ursula Absetz, Pilvikki Lindström, Jaana Pihlajamäki, Jussi Lancet Reg Health Eur Articles BACKGROUND: No real-world randomised controlled trials (RCTs) have explored the effectiveness of lifestyle interventions based on multiple behaviour change theories and using combined digital and group-based face-to-face delivery to improve risk factors for type 2 diabetes (T2D). METHODS: We conducted a one-year, multi-centre, unblinded, pragmatic RCT in primary healthcare using the habit formation, self-determination, and self-regulation theories among 2907 adults aged 18–74 years at increased T2D risk randomised into a digital lifestyle intervention group (DIGI, n = 967), a combined digital and group-based lifestyle intervention group (DIGI+GROUP, n = 971), and a control group receiving usual care (CONTROL, n = 969). We collected data on primary outcomes (diet quality by Healthy Diet Index [HDI], physical activity, body weight, fasting plasma glucose, 2-hour plasma glucose) and secondary outcomes (sedentary time, waist circumference, fasting plasma insulin) using digital questionnaires, clinical examinations, fasting blood tests, and 2-hour oral glucose tolerance tests. Main statistical analyses were performed using linear mixed-effects models adjusted for age, sex, and province. This RCT was registered with ClinicalTrials.gov, NCT03156478. FINDINGS: The 2907 participants assigned were recruited between March 1(st), 2017, and February 28(th), 2018. Diet quality improved more (3·2 vs. 1·4 HDI points, p<0·001 for difference between groups, p’<0·001 for group*time interaction) and waist circumference tended to decrease more (−1·8 vs. −1·3 cm, p = 0·028, p’ = 0·068) in DIGI+GROUP than in CONTROL. Fasting insulin tended to increase in CONTROL but not in DIGI (1·0 vs. 0·0 mU/L, p = 0·033, p’ = 0·054) or in DIGI+GROUP (1·0 vs. 0·5 mU/L, p = 0·042, p’ = 0·054). Good adherence to DIGI and DIGI+GROUP (≥median of 501 habits/year in DIGI, ≥5 of all 6 sessions in GROUP) was associated with improved diet quality and good adherence to DIGI with increased physical activity and decreased sedentary time. INTERPRETATION: A lifestyle intervention based on multiple behaviour change theories and combined digital and group-based face-to-face delivery improves diet quality and tends to decrease abdominal adiposity and prevent an increase in insulin resistance. Good adherence improves the results of the interventions. FUNDING: Strategic Research Council at Academy of Finland, Academy of Finland, Novo Nordisk Foundation, and Finnish Diabetes Research foundation. Elsevier 2022-10-12 /pmc/articles/PMC9810821/ /pubmed/36620354 http://dx.doi.org/10.1016/j.lanepe.2022.100527 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Lakka, Timo A.
Aittola, Kirsikka
Järvelä-Reijonen, Elina
Tilles-Tirkkonen, Tanja
Männikkö, Reija
Lintu, Niina
Karhunen, Leila
Kolehmainen, Marjukka
Harjumaa, Marja
Mattila, Elina
Järvenpää, Riia
Ermes, Miikka
Mikkonen, Santtu
Martikainen, Janne
Poutanen, Kaisa
Schwab, Ursula
Absetz, Pilvikki
Lindström, Jaana
Pihlajamäki, Jussi
Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial
title Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial
title_full Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial
title_fullStr Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial
title_full_unstemmed Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial
title_short Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – A stop diabetes pragmatic randomised trial
title_sort real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk – a stop diabetes pragmatic randomised trial
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810821/
https://www.ncbi.nlm.nih.gov/pubmed/36620354
http://dx.doi.org/10.1016/j.lanepe.2022.100527
work_keys_str_mv AT lakkatimoa realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT aittolakirsikka realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT jarvelareijonenelina realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT tillestirkkonentanja realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT mannikkoreija realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT lintuniina realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT karhunenleila realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT kolehmainenmarjukka realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT harjumaamarja realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT mattilaelina realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT jarvenpaariia realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT ermesmiikka realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT mikkonensanttu realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT martikainenjanne realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT poutanenkaisa realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT schwabursula realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT absetzpilvikki realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT lindstromjaana realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial
AT pihlajamakijussi realworldeffectivenessofdigitalandgroupbasedlifestyleinterventionsascomparedwithusualcaretoreducetype2diabetesriskastopdiabetespragmaticrandomisedtrial